CARILLON TOWER ADVISERS, INC. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 295 filers reported holding HAEMONETICS CORP in Q3 2018. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
CARILLON TOWER ADVISERS, INC. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2020$31,588,011,000
-20.3%
344,7720.0%0.31%
+17.0%
Q4 2019$39,614,303,000
+73945.4%
344,772
-18.7%
0.26%
-29.0%
Q3 2019$53,500,000
+4.8%
424,1330.0%0.37%
+6.3%
Q2 2019$51,040,000
+37.6%
424,1330.0%0.35%
+33.5%
Q1 2019$37,103,000
-12.6%
424,1330.0%0.26%
-26.7%
Q4 2018$42,434,000
-12.7%
424,1330.0%0.36%
+3.2%
Q3 2018$48,597,000424,1330.35%
Other shareholders
HAEMONETICS CORP shareholders Q3 2018
NameSharesValueWeighting ↓
Black Creek Investment Management Inc. 1,014,941$33,077,0003.62%
Camber Capital Management LP 1,202,000$39,173,0003.07%
AMERICAN CAPITAL MANAGEMENT INC 718,380$23,412,0002.76%
Van Berkom & Associates Inc. 1,258,322$41,009,0002.31%
SNYDER CAPITAL MANAGEMENT L P 1,222,547$39,843,0002.07%
KESTREL INVESTMENT MANAGEMENT CORP 441,250$14,380,0001.78%
STONE RUN CAPITAL, LLC 33,740$1,100,0000.80%
HERMES INVESTMENT MANAGEMENT LTD 728,123$23,730,0000.75%
ANCHOR CAPITAL ADVISORS LLC 1,119,060$36,470,0000.73%
Netols Asset Management, Inc. 137,267$4,473,0000.72%
View complete list of HAEMONETICS CORP shareholders